Showing results (31-40 of 293) with videos related to
Sort By:
Pageof 30
Medicine and Science in Sports and Exercise|September 8, 2025
Daily Use of a Broad-Spectrum Cannabidiol Supplement Produces Detectable Concentrations of Cannabinoids in Urine Prohibited by the World Anti-Doping Agency: An Effect Amplified by ExerciseScott H Gillham, Paige L Cole, Daniel J Owens, et al.Behavioral Neuroscience|June 27, 2007
Benzodiazepines impair the acquisition and reversal of olfactory go/no-go discriminations in ratsLjiljana Sokolic, Iain S McGregorDrug Testing and Analysis|December 8, 2022
How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trialsDanielle McCartney, Richard C Kevin, Anastasia S Suraev, et al.Behavioural Brain Research|May 23, 2006
Defensive responses of Wistar and Sprague-Dawley rats to cat odour and TMTLauren G Staples, Iain S McGregorAddictive Behaviors|September 4, 2004
Rats on the grog: novel pharmacotherapies for alcohol cravingIain S McGregor, Jason E GallateBehavioural Brain Research|May 9, 2002
Contrasting effects of dopamine antagonists and frequency reduction on Fos expression induced by lateral hypothalamic stimulationGlenn E Hunt, Iain S McGregorHormones and Behavior|December 27, 2011
Breaking the loop: oxytocin as a potential treatment for drug addictionIain S McGregor, Michael T BowenThe International Journal of Neuropsychopharmacology|May 9, 2014
Oxytocin and vasopressin modulate the social response to threat: a preclinical studyMichael T Bowen, Iain S McGregorAlcoholism, Clinical and Experimental Research|September 20, 2007
Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in ratsGarth A Hargreaves, Iain S McGregorPsychopharmacology|May 17, 2024
Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trialAnastasia Suraev, Danielle McCartney, Nathaniel S Marshall, et al.Pageof 30